{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:51:19Z","timestamp":1780570279164,"version":"3.54.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","bpgastro.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.bpg.2015.05.005","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T06:21:27Z","timestamp":1431584487000},"page":"451-458","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Complications of coeliac disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Georgia","family":"Malamut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Cellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bpg.2015.05.005_bib1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archinte.165.4.393","article-title":"Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis","volume":"165","author":"Stenson","year":"2005","journal-title":"Arch Intern Med"},{"issue":"12","key":"10.1016\/j.bpg.2015.05.005_bib2","first-page":"2130","article-title":"Bone mineral affection in asymptomatic adult patients with celiac disease","volume":"89","author":"Mazure","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2015.05.005_bib3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-230X-11-136","article-title":"Clinical benefit of gluten-free diet in screen-detected older celiac disease patients","volume":"11","author":"Vilppula","year":"2011","journal-title":"BMC Gastroenterol"},{"issue":"4","key":"10.1016\/j.bpg.2015.05.005_bib4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/gut.52.4.518","article-title":"Fracture experience of patients with coeliac disease: a population based survey","volume":"52","author":"Thomason","year":"2003","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bpg.2015.05.005_bib5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0016-5085(95)90276-7","article-title":"Bone mass and metabolism in patients with celiac disease","volume":"109","author":"Corazza","year":"1995","journal-title":"Gastroenterology"},{"issue":"25","key":"10.1016\/j.bpg.2015.05.005_bib6","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.3748\/wjg.v17.i25.3035","article-title":"Risk of fracture in celiac disease: gender, dietary compliance, or both?","volume":"17","author":"Sanchez","year":"2011","journal-title":"World J Gastroenterol WJG"},{"issue":"7","key":"10.1016\/j.bpg.2015.05.005_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cgh.2007.12.022","article-title":"Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet","volume":"6","author":"Cosnes","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.bpg.2015.05.005_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1440-1746.2012.07272.x","article-title":"Celiac disease arthropathy and autoimmunity study","volume":"28","author":"Iqbal","year":"2013","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.bpg.2015.05.005_bib9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1136\/gut.35.9.1215","article-title":"Coeliac disease-associated disorders and survival","volume":"35","author":"Collin","year":"1994","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.bpg.2015.05.005_bib10","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2337\/db08-1551","article-title":"Genome-wide scan for linkage to type 1 diabetes in 2496 multiplex families from the type 1 diabetes genetics consortium","volume":"58","author":"Concannon","year":"2009","journal-title":"Diabetes"},{"issue":"16","key":"10.1016\/j.bpg.2015.05.005_bib11","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMra0808284","article-title":"Genetics of type 1A diabetes","volume":"360","author":"Concannon","year":"2009","journal-title":"New Engl J Med"},{"issue":"10","key":"10.1016\/j.bpg.2015.05.005_bib12","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.bcp.2011.06.023","article-title":"The adaptor Lnk (SH2B3): an emerging regulator in vascular cells and a link between immune and inflammatory signaling","volume":"82","author":"Devalliere","year":"2011","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.bpg.2015.05.005_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1756283X11417038","article-title":"Screening for celiac disease in average-risk and high-risk populations","volume":"5","author":"Aggarwal","year":"2012","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.bpg.2015.05.005_bib14","series-title":"Persistance of villous atrophy and iron deficiency anemia is frequently observed in adult patients with celiac disease after at least one year of gluten free diet","author":"Saadi","year":"2014"},{"issue":"3","key":"10.1016\/j.bpg.2015.05.005_bib15","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-159-3-201308060-00006","article-title":"Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study","volume":"159","author":"Lebwohl","year":"2013","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.bpg.2015.05.005_bib16","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1572-0241.2003.07284.x","article-title":"Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease","volume":"98","author":"Vahedi","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.bpg.2015.05.005_bib17","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cgh.2007.05.013","article-title":"Adult autoimmune enteropathy: Mayo Clinic Rochester experience","volume":"5","author":"Akram","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2015.05.005_bib18","first-page":"133","article-title":"Tropical sprue: revisited","volume":"54","author":"Khokhar","year":"2004","journal-title":"J\u00a0Pak Med Assoc"},{"issue":"10","key":"10.1016\/j.bpg.2015.05.005_bib19","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/ajg.2010.214","article-title":"The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease","volume":"105","author":"Malamut","year":"2010","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.bpg.2015.05.005_bib20","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0016-5085(98)70530-X","article-title":"Abnormal intestinal intraepithelial lymphocytes in refractory sprue","volume":"114","author":"Cellier","year":"1998","journal-title":"Gastroenterology"},{"issue":"9225","key":"10.1016\/j.bpg.2015.05.005_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","article-title":"Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group","volume":"356","author":"Cellier","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.bpg.2015.05.005_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","article-title":"Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II","volume":"136","author":"Malamut","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2015.05.005_bib23","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/gut.2006.114512","article-title":"Survival in refractory coeliac disease and enteropathy associated T cell lymphoma: retrospective evaluation of single centre experience","volume":"56","author":"Al-Toma","year":"2007","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.bpg.2015.05.005_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.gastro.2008.11.026","article-title":"Celiac disease and its complications: a time traveller's perspective","volume":"136","author":"West","year":"2009","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bpg.2015.05.005_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/ajg.2011.104","article-title":"The incidence and clinical spectrum of refractory celiac disease in a north american referral center","volume":"106","author":"Roshan","year":"2011","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.bpg.2015.05.005_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2008.10.013","article-title":"Clinical staging and survival in refractory celiac disease: a single center experience","volume":"136","author":"Rubio-Tapia","year":"2009","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bpg.2015.05.005_bib27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/MEG.0b013e328307c20c","article-title":"High rates of complications and substantial mortality in both types of refractory sprue","volume":"21","author":"Daum","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.bpg.2015.05.005_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cgh.2005.12.011","article-title":"Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma","volume":"4","author":"Al-Toma","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2015.05.005_bib29","series-title":"Abstract book celiac disease symposium Firenze","article-title":"Genetic and risk for associated autoimmune disorders and refractory coeliac disease mastering the coeliac condition","author":"Wijmenga","year":"2012"},{"issue":"3","key":"10.1016\/j.bpg.2015.05.005_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bpg.2005.02.001","article-title":"Refractory coeliac disease","volume":"19","author":"Daum","year":"2005","journal-title":"Best Pract Res"},{"key":"10.1016\/j.bpg.2015.05.005_bib31","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MCG.0b013e31823eff20","article-title":"TCRbeta clonality improves diagnostic yield of TCRgamma clonality in refractory celiac disease","volume":"46","author":"Perfetti","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"6","key":"10.1016\/j.bpg.2015.05.005_bib32","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2012.08.028","article-title":"Large granular lymphocytic leukemia: a treatable form of refractory celiac disease","volume":"143","author":"Malamut","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bpg.2015.05.005_bib33","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.cgh.2013.11.028","article-title":"Small intestinal CD4+ T-cell lymphoma is a heterogenous entity with common pathology features","volume":"12","author":"Malamut","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2015.05.005_bib34","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/s-2007-966239","article-title":"Capsule endoscopy in refractory celiac disease","volume":"39","author":"Daum","year":"2007","journal-title":"Endoscopy"},{"issue":"10","key":"10.1016\/j.bpg.2015.05.005_bib35","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/ajg.2012.199","article-title":"Diagnostic yield of capsule endoscopy in refractory celiac disease","volume":"107","author":"Barret","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.bpg.2015.05.005_bib36","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2036.2003.01687.x","article-title":"Azathioprine and prednisone combination therapy in refractory coeliac disease","volume":"18","author":"Goerres","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.bpg.2015.05.005_bib37","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1136\/gut.2005.089987","article-title":"A\u00a0severe but reversible refractory sprue","volume":"55","author":"Dray","year":"2006","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.bpg.2015.05.005_bib38","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.cgh.2006.07.007","article-title":"Cladribine therapy in refractory celiac disease with aberrant T cells","volume":"4","author":"Al-Toma","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.bpg.2015.05.005_bib39","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1182\/blood-2006-08-042820","article-title":"Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T-cells","volume":"109","author":"Al-Toma","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bpg.2015.05.005_bib40","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/bmt.2010.199","article-title":"Auto-SCT in refractory celiac disease type II patients unresponsive to cladribine therapy","volume":"46","author":"Tack","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bpg.2015.05.005_bib41","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1172\/JCI41344","article-title":"IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis","volume":"120","author":"Malamut","year":"2010","journal-title":"J\u00a0Clin Invest"},{"issue":"9","key":"10.1016\/j.bpg.2015.05.005_bib42","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/art.21363","article-title":"Targeting the interleukin-15 system in rheumatoid arthritis","volume":"52","author":"Waldmann","year":"2005","journal-title":"Arthritis Rheumatism"},{"issue":"3","key":"10.1016\/j.bpg.2015.05.005_bib43","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s10875-012-9849-y","article-title":"Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease","volume":"33","author":"Yokoyama","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"issue":"3","key":"10.1016\/j.bpg.2015.05.005_bib44","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/art.33383","article-title":"Phase IIb dose-ranging study of the oral JAK inhibitor tofacitinib (CP-690,550) or adalimumab monotherapy versus placebo in patients with active rheumatoid arthritis with an inadequate response to disease-modifying antirheumatic drugs","volume":"64","author":"Fleischmann","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.bpg.2015.05.005_bib45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.dld.2012.12.001","article-title":"Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study","volume":"45","author":"Malamut","year":"2013","journal-title":"Dig Liver Dis"},{"issue":"12","key":"10.1016\/j.bpg.2015.05.005_bib46","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1023\/A:1026655609906","article-title":"Mortality and causes of death in celiac disease in a Mediterranean area","volume":"44","author":"Cottone","year":"1999","journal-title":"Dig Dis Sci"},{"issue":"9279","key":"10.1016\/j.bpg.2015.05.005_bib47","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(01)05554-4","article-title":"Mortality in patients with coeliac disease and their relatives: a cohort study","volume":"358","author":"Corrao","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.bpg.2015.05.005_bib48","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1053\/gast.2002.36585","article-title":"Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis","volume":"123","author":"Askling","year":"2002","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.bpg.2015.05.005_bib49","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1080\/00365520802240222","article-title":"Incidence of enteropathy\u2013associated T-cell lymphoma: a nation-wide study of a population-based registry in The Netherlands","volume":"43","author":"Verbeek","year":"2008","journal-title":"Scand J Gastroenterol"},{"issue":"15","key":"10.1016\/j.bpg.2015.05.005_bib50","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1002\/cncr.26700","article-title":"Increasing incidence of enteropathy-associated T-cell lymphoma in the United States, 1973\u20132008","volume":"118","author":"Sharaiha","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bpg.2015.05.005_bib51","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/archpediatrics.2007.38","article-title":"Emerging new clinical patterns in the presentation of celiac disease","volume":"162","author":"Telega","year":"2008","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"11","key":"10.1016\/j.bpg.2015.05.005_bib52","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.2009.1366","article-title":"Mortality in celiac disease, intestinal inflammation, and gluten sensitivity","volume":"302","author":"Green","year":"2009","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.bpg.2015.05.005_bib53","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/cncr.25524","article-title":"Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans","volume":"117","author":"Landgren","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bpg.2015.05.005_bib54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0016-5085(03)00692-9","article-title":"Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue","volume":"125","author":"Verkarre","year":"2003","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.bpg.2015.05.005_bib55","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/gut.52.3.347","article-title":"18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) for assessment of enteropathy-type T cell lymphoma","volume":"52","author":"Hoffmann","year":"2003","journal-title":"Gut"},{"issue":"18","key":"10.1016\/j.bpg.2015.05.005_bib56","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2009-07-231324","article-title":"Evaluation of enteropathy-associated T-cell lymphoma comparing standard therapies with a novel regimen including autologous stem cell transplantation","volume":"115","author":"Sieniawski","year":"2011","journal-title":"Blood"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691815000591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691815000591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T16:26:00Z","timestamp":1537633560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691815000591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1521691815000591"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2015.05.005","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complications of coeliac disease","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2015.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}